Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China

Table 1 Clinical characteristics of seven CR-hvAB isolates

Patient	Age-range	Isolate	Department	Date of isolation	Diagnosis	Underlying diseases	Outcome	MLST	Resistant phenotype
1	10–20	AB102–9	ICU	2019.5.14	Severe pneumonia	–	Recovered	ST457	TZP, CRO, CAZ, CFP, IPM, MEM, AK, GEN, CIP
2	20–30	AB21	ICU	2018.2.17	Severe pneumonia	DM	Death	ST369	TZP, CRO, CAZ, CFP, IPM, MEM, AK, GEN, CIP, TMP-SMZ
3	60–70	AB22	ICU	2018.3.9	Sepsis	DM	Death	ST457	TZP, CRO, CAZ, CFP, IPM, MEM, AK, GEN, CIP
4	30–40	AB80	SD	2018.1.11	Wound	–	Recovered	ST2088	TZP, CRO, CAZ, CFP, IPM, MEM, CIP, TMP-SMZ
5	60–70	AB98	ICU	2017.1.17	Sepsis	DM	Death	ST457	TZP, CRO, CAZ, CFP, IPM, MEM, AK, GEN, CIP
6	60–70	AB112	ICU	2017.4.15	Septic shock	DM	Death	ST195	TZP, CRO, CAZ, CFP, IPM, MEM, AK, GEN, CIP
7	60–70	AB150	ICU	2017.10.4	Septic shock	–	Death	ST457	TZP, CRO, CAZ, CFP, IPM, MEM, AK, GEN, CIP

ICU intensive care unit, SD surgical department, DM Diabetes; −, No underlying diseases, TZP piperacillin / tazobactam, CRO Ceftriaxone, CAZ ceftazidime, IPM imipenem, MEM meropenem, GEN gentamicin, AK amikacin, CIP ciprofloxacin, CFP cefepime, TMP-SMZ trimethoprim and sulphame-thoxazole

ISSN: 1471-2180